palmostatin M: inhibits acyl protein thioesterases 1 and 2; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 56641205 |
CHEMBL ID | 3133031 |
MeSH ID | M0582002 |
Synonym |
---|
CHEMBL3133031 , |
bdbm50496629 |
palmostatin m |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Acyl-protein thioesterase 1 | Homo sapiens (human) | IC50 (µMol) | 0.0025 | 0.0025 | 1.1761 | 3.5500 | AID1079563 |
Acyl-protein thioesterase 2 | Homo sapiens (human) | IC50 (µMol) | 0.0196 | 0.0196 | 1.2873 | 3.5500 | AID1079562 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
protein depalmitoylation | Acyl-protein thioesterase 1 | Homo sapiens (human) |
fatty acid metabolic process | Acyl-protein thioesterase 1 | Homo sapiens (human) |
fatty acid transport | Acyl-protein thioesterase 1 | Homo sapiens (human) |
negative regulation of Golgi to plasma membrane protein transport | Acyl-protein thioesterase 1 | Homo sapiens (human) |
negative regulation of aggrephagy | Acyl-protein thioesterase 1 | Homo sapiens (human) |
protein depalmitoylation | Acyl-protein thioesterase 2 | Homo sapiens (human) |
fatty acid metabolic process | Acyl-protein thioesterase 2 | Homo sapiens (human) |
axon guidance | Acyl-protein thioesterase 2 | Homo sapiens (human) |
acylglycerol catabolic process | Acyl-protein thioesterase 2 | Homo sapiens (human) |
prostaglandin catabolic process | Acyl-protein thioesterase 2 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
phospholipase activity | Acyl-protein thioesterase 1 | Homo sapiens (human) |
lysophospholipase activity | Acyl-protein thioesterase 1 | Homo sapiens (human) |
protein binding | Acyl-protein thioesterase 1 | Homo sapiens (human) |
palmitoyl-(protein) hydrolase activity | Acyl-protein thioesterase 1 | Homo sapiens (human) |
lipase activity | Acyl-protein thioesterase 1 | Homo sapiens (human) |
carboxylic ester hydrolase activity | Acyl-protein thioesterase 1 | Homo sapiens (human) |
lysophospholipase activity | Acyl-protein thioesterase 2 | Homo sapiens (human) |
protein binding | Acyl-protein thioesterase 2 | Homo sapiens (human) |
palmitoyl-(protein) hydrolase activity | Acyl-protein thioesterase 2 | Homo sapiens (human) |
cadherin binding | Acyl-protein thioesterase 2 | Homo sapiens (human) |
carboxylic ester hydrolase activity | Acyl-protein thioesterase 2 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1079563 | Inhibition of APT1 (unknown origin) | 2014 | MedChemComm, Mar, Volume: 5, Issue:3 | Acyl protein thioesterase inhibitors as probes of dynamic S-palmitoylation. |
AID1206942 | Inhibition of Staphylococcus aureus caseinolytic protein protease using fluorogenic substrate assessed as residual activity at 10 uM after 15 mins | 2015 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 25, Issue:11 | De novo design of caseinolytic protein proteases inhibitors based on pharmacophore and 2D molecular fingerprints. |
AID1079562 | Inhibition of APT2 (unknown origin) | 2014 | MedChemComm, Mar, Volume: 5, Issue:3 | Acyl protein thioesterase inhibitors as probes of dynamic S-palmitoylation. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.80) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |